Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway

Fig. 2

FAM168A may be involved in the regulation of AKT1/NFκB signaling pathway in K562 cells. K562 cells were transfected with FAM168A siRNA or negative control siRNA, respectively. a The changes in AKT1, p-AKT1 and IκB-α levels in whole cell lysates. b The change in NFκB protein in nuclear extracts. Data were presented as mean ± SD from three independent experiments. **p < 0.01

Back to article page